Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Data Collection and Analysis of COVID-19 Patients Treated With ClorNovir® (Chlorpheniramine Maleate (0.4% Nasal Spray)

NCT05520944 is registered in ClinicalTrials.gov with Dr. Ferrer BioPharma as lead sponsor.

NCT NCT05520944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05520944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Data Collection and Analysis of COVID-19 Patients Treated With ClorNovir® (Chlorpheniramine Maleate (0.4% Nasal Spray)
Lead sponsor
Dr. Ferrer BioPharma
Phase
Observational
Overall status
Unknown status
Start date
August 26, 2021
Completion date
October 1, 2022
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, covid-19 pandemic, covid-19 respiratory infection, sars cov 2 infection, sars-cov-2 acute respiratory disease